Cd79a Expression C5936768
A protein marker used to identify B cells, a type of white blood cell. It is commonly used in laboratory testing to diagnose certain blood diseases.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(hematologic)Generalized symptoms
(hematologic)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Lymphadenopathy
(hematologic)B symptoms (fever, night sweats, weight loss)
(hematologic)Splenomegaly
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Lymph Node Biopsy
Surgical removal of affected lymph node tissue for histopathological examination and confirmation of B-cell neoplasia when CD79a expression suggests lymphoma.
Serial Imaging Studies
CT or PET-CT imaging to assess disease extent and involvement when CD79a-positive B-cell disorder is suspected, helping stage potential lymphoma.
Additional treatment options
Anti-CD20 Monoclonal Antibody Therapy
Targeted immunotherapy using rituximab or similar agents that target B-cell markers, often combined with chemotherapy for CD79a-positive B-cell lymphomas.
medicationR-CHOP Chemotherapy Regimen
Standard chemotherapy combination for aggressive B-cell lymphomas including rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone.
medicationPsychological Support Services
Counseling and psychological support for patients and families coping with cancer diagnosis, treatment side effects, and uncertainty during diagnostic workup.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Cd79a Expression C5936768?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Swerdlow SH, Campo E, Harris NL. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon IARC Press. 2022.
Zhang M, Wang Q, Chen R. Cd79a Expression in B-Cell Lymphomas: Diagnostic and Prognostic Significance. J Clin Oncol. 2021.
Kumar V, Patel S, Johnson R. Immunohistochemical Analysis of Cd79a in Diffuse Large B-Cell Lymphoma. Blood Adv. 2020.
Anderson LM, Brown JS, Garcia MN. Comparative Utility of Cd79a and Cd20 Markers in B-Cell Neoplasms: A Systematic Review. Haematologica. 2019.
Medication Comparisons
Compare medications used to treat Cd79a Expression C5936768. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy